期刊文献+

胆道系统神经内分泌肿瘤的病理和预后 被引量:1

Clinical features and prognosis of extrahepatic biliary neuroendocrine neoplasms
原文传递
导出
摘要 目的探讨肝外胆道系统神经内分泌肿瘤(extrahepatic biliary neuroendocrine neoplasms,EB-NENs)的临床病理特征及影响预后的因素。方法回顾性分析2014年5月至2018年5月收治的21例EB-NENs患者临床资料和生存情况。结果EB-NENs占同期全部胆道系统肿瘤总数的1.6%(21/1313),就诊时淋巴结转移7例(33.3%),远处转移5例(23.8%);至随访结束,中位生存时间(23.23±4.17)个月;单因素分析显示,TNM分期(χ^2=9.066,P=0.003)、淋巴结转移(χ^2=6.399,P=0.011)和远处转移(χ^2=9.808,P=0.002)是影响预后的相关危险因素。多因素分析显示,TNM分期(P=0.008,RR=3.003,95%CI:1.332~6.774)、淋巴结转移(P=0.023,RR=5.382,95%CI:1.261~22.971)和远处转移(P=0.007,RR=7.423,95%CI:1.730~31.851)是影响预后的独立危险因素。结论EB-NENs发病率低,预后差。TNM分期、淋巴结转移和远处转移是影响患者预后的独立危险因素。 Objective To investigate the clinical features and prognostic factors of extrahepatic biliary neuroendocrine neoplasms(EB-NENs).Methods The clinical data and survival of 21 patients with EB-NENs admitted from May 2014 to May 2018 were analyzed retrospectively.Results These 21 EB-NENs patients accounted for 1.6%(21/1313)of all biliary tract neoplasms treated during the study period.Seven(33.3%)cases had lymph node metastasis.Five(23.8%)suffered from distant metastasis.The follow up time was(4~46.5)months with median survival time of(23.23±4.17)months.Univariate analysis showed that the risk factors for survival were tumor TNM stage(χ^2=9.066,P=0.003),lymph node metastasis(χ^2=6.399,P=0.011)and distant metastasis(χ^2=9.808,P=0.002).By multivariate analysis,independent risk factors were tumor TNM stage(P=0.008,RR=3.003,95%CI:1.332~6.774),lymph node metastasis(P=0.023,RR=5.382,95%CI:1.261~22.971)and distant metastasis or not(P=0.007,RR=7.423,95%CI:1.730~31.851).Conclusion EB-NENs was a rare malignant tumor with poor prognosis.Tumor TNM stage,lymph node metastasis and distant metastasis were independent prognostic factors for EB-NENs patients.
作者 钱国武 黄晶晶 段鑫鑫 孙万日 刘驰 宋展 Qian Guowu;Huang Jinxing;Duan Xinxin;Sun Wanri;Liu Chi;Song Zhan(Department of General Surgery,the Affiliated Nanyang Central Hospital,Zhengzhou University,Nanyang 473009,China;Department of General Surgery,the First Hospital Affiliated to Henan University of Chinese Medicine,Zhengzhou 450000,China;Department of Hepatobiliary Surgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处 《中华普通外科杂志》 CSCD 北大核心 2019年第11期964-967,共4页 Chinese Journal of General Surgery
关键词 胆囊肿瘤 神经内分泌瘤 胆总管肿瘤 存活率分析 Gallbladder neoplasms Neuroendocrine tumors Common bile duct neoplasms Survival analysis
  • 相关文献

参考文献2

二级参考文献19

  • 1李强,穆钰瑾.肝外胆道类癌的临床诊治[J].中华肝胆外科杂志,2005,11(3):195-196. 被引量:7
  • 2OBERG K. Neuroendocrine tumours ( NETs ) ~ historical overview and epidemiology[J]. Tumori, 2010, 96(5) : 797 -801.
  • 3KOMMINOTH P, ARNOLD R, CAPELLA C, et at. Neuroen- docrine neoplasms of the gallbladder and extrahepatic bile ducts[ M]. WHO Classification of Tumours of the Digestive System, 2010 : 274 -276.
  • 4ALBORES -SAAVEDRA J, NADJI M, HENSON DE, et al. Intestinal metaplasia of the gallbladder, a morphologic and immunocytochemical study[ J ]. Hum Pathol, 1986, 17 ( 6 ) ~ 614 -620.
  • 5KULKE MH. Neuroendocrine tumours: clinical presentation and management of localized disease [ J ]. Cancer Treat Rev, 2003, 29(5) : 363 -370.
  • 6OBERG K, ERIKSSON B. Nuclearmedicine in the detection, staging and treatment of gastrointestinal carcinoid tumours [J]. Best Pract Res Clin Endocrinol Metab, 2005, 19(2): 265 -276.
  • 7VINIK AI, WOLTERJING EA, WARNER RR, et al. NANETS consensus guidelines for the diagnosis of Neuroendocrine tumour[J]. Pancreas, 2010, 39(6):713-734.
  • 8LAMBERTS SW, HOFLAND L J, NOBELS FR. Neuroendocrine tumor markers[J]. Front Neuroendocrinol, 2001,22(4): 309- 339.
  • 9STRIDSBERG M, ERIKSSON B, OBERG K, et al. A comparison between three commercial kits for chromogranin a measure monts[J]. J Endocrinol, 2003, 177(2) : 337 -341.
  • 10BAUDIN E. Gastroenteropancreatic endocrine tumors: clini- cal characterization before therapy [ J]. Nat Clin Pract Endo- crinol Metab, 2007, 3(3): 228-239.

共引文献10

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部